Viewing Study NCT00251433


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2026-01-24 @ 7:31 AM
Study NCT ID: NCT00251433
Status: TERMINATED
Last Update Posted: 2023-03-31
First Post: 2005-11-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer
Sponsor:
Organization: